Herbs (Global Traditional) · Traditional Chinese Medicine
Acorus gramineus (Japanese Sweet Flag)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Acorus gramineus (Japanese Sweet Flag) is a Kampo herb containing β-asarone as its primary bioactive compound, which modulates neurotransmitter activity and exhibits antimicrobial properties. The volatile oil components demonstrate antibacterial effects in laboratory studies while traditional use focuses on cognitive and digestive support.
Acorus gramineus (Japanese Sweet Flag) is a perennial herbaceous plant native to East Asia, distinct from common Sweet Flag (A. calamus), with lower β-asarone levels. The dried rhizomes and roots are processed via hydro-distillation for essential oil extraction or solvent extraction for other bioactive constituents.
No human clinical trials, RCTs, or meta-analyses for Acorus gramineus were identified in the research. Limited pharmacological data exists only for in vitro antibacterial activity of volatile oils, with no PMIDs provided for human studies.
No clinically studied dosage ranges are available for Acorus gramineus extracts, powders, or standardized forms due to absence of human trials. Traditional uses do not specify standardization parameters or specific dosing protocols. Consult a healthcare provider before starting any new supplement.
Acorus gramineus is not consumed as a food ingredient in meaningful quantities, so macronutrient and caloric profiling is not clinically relevant. Its value lies in its bioactive phytochemical composition. Key documented compounds include: (1) Volatile oils (0.5–3.5% of dry rhizome weight) dominated by β-asarone (up to 80–96% of volatile fraction in some Asian chemotypes) and α-asarone (5–10%), with trace amounts of eugenol, methyleugenol, and caryophyllene — note: β-asarone is a known hepatotoxin and potential carcinogen at high doses, distinguishing it from the North American Acorus calamus var. americanus which lacks β-asarone; (2) Phenylpropanoids including asaricin and methylisoeugenol; (3) Alkaloids: acoradin, galanamine precursors, and acoramine in trace amounts (<0.1% dry weight); (4) Sesquiterpenes: acorenone, shyobunone, and isoshyobunone contributing to sedative-adjacent activity; (5) Flavonoids: luteolin and apigenin glycosides at low concentrations (~0.05–0.2% dry weight); (6) Tannins and phenolic acids including ferulic acid and p-coumaric acid (~0.1–0.3% dry weight); (7) Starch content in rhizome is relatively high (~20–35% dry weight) but not nutritionally exploited; (8) Mineral content is modest — trace potassium, calcium, and magnesium detected in rhizome tissue but not at nutritionally significant levels; (9) Fiber present structurally (~15–20% dry weight as lignocellulosic material) but not bioavailable in typical medicinal doses (0.5–3g dried rhizome). Bioavailability note: β-asarone is lipophilic and readily absorbed across gastrointestinal membranes; water-soluble phenolics have moderate bioavailability but are present in small absolute quantities at standard doses. Data on human pharmacokinetics of most minor constituents remains limited to animal models.
β-asarone, the main active compound in Acorus gramineus, appears to modulate GABA and acetylcholine neurotransmitter systems, potentially affecting cognitive function. The volatile oil components, including α-asarone and eugenol, demonstrate antimicrobial activity by disrupting bacterial cell membrane integrity. Additional compounds may influence digestive enzyme activity and gastric motility through cholinergic pathways.
Current evidence for Acorus gramineus is limited to in vitro studies and traditional use documentation. Laboratory studies have confirmed antibacterial activity of volatile oil extracts against various bacterial strains, but no human clinical trials have been conducted. Traditional use in Kampo and TCM spans over 1,500 years for cognitive enhancement and digestive support, though this lacks modern scientific validation. The evidence quality remains preliminary, requiring controlled human studies to establish therapeutic efficacy and optimal dosing protocols.
β-asarone content raises potential safety concerns, as high doses may cause neurotoxic effects in animal studies. No established human safety profile exists due to lack of clinical trials. Potential interactions with sedative medications and cholinesterase inhibitors are theoretically possible due to neurotransmitter effects. Pregnant and nursing women should avoid use due to insufficient safety data and potential asarone toxicity concerns.
